Healthcare provider profile · identity verified

Morvarid Behdin, D.O

Internal Medicine · ORANGE, CA · NPI 1396276754

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	347	144
Amlodipine Besylate	Amlodipine Besylate	287	115
Levothyroxine Sodium	Levothyroxine Sodium	240	99
Rosuvastatin Calcium	Rosuvastatin Calcium	229	102
Omeprazole	Omeprazole	199	83
Lisinopril	Lisinopril	193	79
Losartan Potassium	Losartan Potassium	172	75
Trazodone Hcl	Trazodone Hcl	136	47
Hydrochlorothiazide	Hydrochlorothiazide	127	53
Potassium Chloride	Potassium Chloride	121	47
Metformin Hcl	Metformin Hcl	112	47
Metoprolol Tartrate	Metoprolol Tartrate	112	42
Simvastatin	Simvastatin	112	52
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	105	31
Metformin Hcl Er	Metformin Hcl	105	46
Albuterol Sulfate Hfa	Albuterol Sulfate	104	66
Gabapentin	Gabapentin	91	43
Meloxicam	Meloxicam	83	36
Atenolol	Atenolol	76	33
Glipizide	Glipizide	71	32
Furosemide	Furosemide	69	30
Humulin N	Insulin Nph Human Isophane	67	18
Alendronate Sodium	Alendronate Sodium	62	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	22
Pradaxa	Dabigatran Etexilate Mesylate	55	20
Ozempic	Semaglutide	48	suppressed
Buspirone Hcl	Buspirone Hcl	46	11
Escitalopram Oxalate	Escitalopram Oxalate	45	17
Ezetimibe	Ezetimibe	45	14
Fluoxetine Hcl	Fluoxetine Hcl	45	15
Jardiance	Empagliflozin	41	18
Tamsulosin Hcl	Tamsulosin Hcl	40	15
Donepezil Hcl	Donepezil Hcl	37	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	11
Sertraline Hcl	Sertraline Hcl	35	17
Arexvy	Rsvpref3 Antigen/As01e/Pf	32	32
Estradiol	Estradiol	30	18
Tramadol Hcl	Tramadol Hcl	30	12
Triamcinolone Acetonide	Triamcinolone Acetonide	30	25
Pantoprazole Sodium	Pantoprazole Sodium	28	16
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	13
Humulin R	Insulin Regular, Human	26	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	25	25
Eliquis	Apixaban	25	12
Cefadroxil	Cefadroxil	24	20
Fenofibrate	Fenofibrate	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Prednisone	Prednisone	24	22
Wixela Inhub	Fluticasone Propion/Salmeterol	24	suppressed
Ciclopirox	Ciclopirox	23	12
Clopidogrel	Clopidogrel Bisulfate	23	14
Valacyclovir	Valacyclovir Hcl	23	11
Doxycycline Monohydrate	Doxycycline Monohydrate	22	20
Ondansetron Odt	Ondansetron	22	11
Pregabalin	Pregabalin	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Rizatriptan	Rizatriptan Benzoate	21	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Allopurinol	Allopurinol	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Azithromycin	Azithromycin	18	18
Glipizide Er	Glipizide	17	suppressed
Hydrocortisone	Hydrocortisone	17	14
Ibuprofen	Ibuprofen	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	16	suppressed
Amoxicillin	Amoxicillin	14	12
Carvedilol	Carvedilol	14	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	14	14
Famotidine	Famotidine	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Montelukast Sodium	Montelukast Sodium	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Bupropion Xl	Bupropion Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Finasteride	Finasteride	12	suppressed
Naltrexone Hcl	Naltrexone Hcl	12	suppressed
Lorazepam	Lorazepam	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error